ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.71 USD 0.59% Market Closed
Market Cap: 75.9m USD

Relative Value

There is not enough data to reliably calculate the relative value of EPIX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.1
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-6.8
Industry
23
Forward
-2.4
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-8.9
Industry
19.4
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-8.9
Industry
23.1
vs History
85
vs Industry
68
Median 3Y
0.9
Median 5Y
1.8
Industry
2.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.5
vs History
30
vs Industry
3
Median 3Y
302.5
Median 5Y
-1 197.6
Industry
9.4
vs History
20
vs Industry
17
Median 3Y
0.7
Median 5Y
-2.9
Industry
4.4
vs History
20
vs Industry
15
Median 3Y
0.7
Median 5Y
-2.9
Industry
4.5
Forward
1.1
vs History
19
vs Industry
17
Median 3Y
1
Median 5Y
-4.1
Industry
5.2
vs History
19
vs Industry
13
Median 3Y
1
Median 5Y
-4.1
Industry
3.7
vs History
vs Industry
18
Median 3Y
-72.5
Median 5Y
12
Industry
4.8

Multiples Across Competitors

EPIX Competitors Multiples
ESSA Pharma Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
ESSA Pharma Inc
NASDAQ:EPIX
75.9m USD 0 -2.7 1.1 1.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 698 702.5 -164 917.8 -200 262.8 -197 977.5
US
Abbvie Inc
NYSE:ABBV
337.9B USD 5.9 81.8 15.5 23
US
Amgen Inc
NASDAQ:AMGN
157.2B USD 4.6 26.7 14.3 23.6
US
Gilead Sciences Inc
NASDAQ:GILD
136.7B USD 4.8 23 10.1 13.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD 10.6 -119.2 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 030.3 -518.1 -564.1 -549.1
AU
CSL Ltd
ASX:CSL
116.6B AUD 5 27.7 17.1 21.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56B USD 4 12.6 11.2 12.5
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60 -64.6 -58.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.1B USD 16.7 -145.3 -651.2 -326.3
P/S Multiple
Revenue Growth P/S to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average P/S: 3 470 080.4
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 698 702.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.6
10%
1.1
US
E
Epizyme Inc
F:EPE
2 030.3
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4
4%
1
US
S
Seagen Inc
F:SGT
19.6
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.7
29%
0.6
P/E Multiple
Earnings Growth PEG
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average P/E: 34.4
Negative Multiple: -2.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 917.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.7
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -518.1 N/A N/A
AU
CSL Ltd
ASX:CSL
27.7
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.6
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -145.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBITDA: 13.5
1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -200 262.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.2
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -651.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBIT: 17.4
1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 977.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.6
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.9
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -549.1 N/A N/A
AU
CSL Ltd
ASX:CSL
21.4
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -326.3 N/A N/A